The Serum Institute of India (SII), the world’s biggest vaccine maker, has developed the country’s first cervical cancer shot that will hit the market soon, the company and the government said on Thursday.
https://www.pharmalive.com/wp-content/uploads/2022/09/ReutersAdarPoonwalla9-1-2022.jpg7891200Reuters Healthhttps://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.pngReuters Health2022-09-01 07:17:482022-09-01 11:03:11India develops its first cervical cancer vaccine